Information about Invigo Therapeutics

Error or anomaly*

My details

Full name*

Email address*

Phone*

Invigo Therapeutics (SRL)

BE 0789.481.317

Nonnenstraat 23, 2800 Mechelen

Follow-up

Company information

Status

Active

Enterprise number

BE0789.481.317

VAT liability

Yes

Established

08-08-2022

Last balance sheet year

2025

Company size

Micro 0 FTE

Principal activity

Manufacture of other pharmaceutical products

Health barometer

Credit limit

Are you looking for more information about this company?

Consult health at a glance
Choose quick insights or granular details
Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Invigo Therapeutics

Table Graph

	2025		2024
Profit/Loss	€ -16,600	-4559 %	€ -356
Equity	€ -6,956	-172 %	€ 9,644
Gross margin	€ -7,311	-2537 %	€ 300

Publications from Invigo Therapeutics

	Date	Publication
	10-08-2022	Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of Invigo Therapeutics?

The VAT number of Invigo Therapeutics is BE 0789.481.317.

Wat is the PEPPOL ID of Invigo Therapeutics?

There is no information available about the PEPPOL ID of Invigo Therapeutics or the company is not yet registered on the PEPPOL network.

When was Invigo Therapeutics founded?

Invigo Therapeutics was founded on 08-08-2022.

What is the address of Invigo Therapeutics?

The current registered office of Invigo Therapeutics is located at Nonnenstraat 23, 2800 Mechelen.

When was the last time Invigo Therapeutics filed their annual financial statements?

The most recent financial statements of Invigo Therapeutics were filed on 01-11-2025.

How many employees does Invigo Therapeutics have?

There are currently no employees working at Invigo Therapeutics or no workforce information is available.

What is the annual turnover of Invigo Therapeutics?

At the time of its most recent financial statements, Invigo Therapeutics did not publish any turnover figures. Invigo Therapeutics reported a gross margin of -€7,310.64.